Gene expression profiles from fresh-frozen biopsy sections of 46 tumours and normoxia- and hypoxia-treated cell lines were derived using Illumina bead arrays HT-12 v4 (Illumina Inc., San Diego, CA, USA) with ∼47 300 transcripts, as described by Halle et al (2012) (link). Total RNA was isolated using the RNeasy MiniKit (Qiagen, Hilden, Germany). RNA quality control was performed with Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). cRNA was synthesised, labelled and hybridised to the arrays. Signal extraction and quantile normalisation were carried out using the software provided by the manufacturer (Illumina Inc.). Log-transformed data were used in all analyses. The data have been deposited to the Gene Expression Omnibus (GEO) repository (GSE55935).
>
Chemicals & Drugs
>
Organic Chemical
>
Pimonidazole
Pimonidazole
Pimonidazole: A 2-nitroimidazole compound used as a hypoxia marker in tumor cells.
It accumulates in cells with low oxygen levels, allowing visualization and quantification of tumor hypoxia.
Pimonidazole research is crucial for understanding tumor metabolism and developing targeted therapies.
Optimize your Pimonidazole studies with PubCompare.ai, an innovative tool that uses AI to easily locate the best protocols from literature, preprints, and patents.
Enhance reproducibility and accuuracy in your research, and experience the future of research optimization today.
It accumulates in cells with low oxygen levels, allowing visualization and quantification of tumor hypoxia.
Pimonidazole research is crucial for understanding tumor metabolism and developing targeted therapies.
Optimize your Pimonidazole studies with PubCompare.ai, an innovative tool that uses AI to easily locate the best protocols from literature, preprints, and patents.
Enhance reproducibility and accuuracy in your research, and experience the future of research optimization today.
Most cited protocols related to «Pimonidazole»
Biopsy
Cell Lines
Complementary RNA
Frozen Sections
Gene Expression
Hypoxia
Neoplasms
Gene expression profiles were combined with pimonidazole data in a two-step procedure described previously (Halle et al, 2012 (link)). First, an explorative, unsupervised analysis was performed. The investigation cohort was split into a pimonidazole-positive and -negative group according to an immunoscore of <2 (n=21) or ⩾2 (n=18), and the Linear Models for Microarray Data software was applied to find genes differentially expressed between the groups. A nominal P-value of 0.05 was used as cutoff, resulting in an appropriate number of about 1000 genes. Biological processes enriched in the pimonidazole-positive group were analysed using the DAVID gene ontology (GO) software (Huang et al, 2009 (link)), where a false discovery rate of <10% (q<0.1) was considered to be significant.
Second, a supervised gene set enrichment analysis was performed with 21 gene sets covering the significant biological processes from the GO analysis, using the Significance Analysis of Microarrays for Gene Sets (SAM-GS) software, which is based on the moderated t-statistics in SAM (Dinu et al, 2007 ). All gene sets were collected from the Molecular Signatures Database except a prostate cancer-specific hypoxia gene set constructed in this work, two hypoxia gene sets constructed in head and neck (Toustrup et al, 2011 (link)) and cervical cancer (Halle et al, 2012 (link)) and two target gene sets of the hypoxia-inducible factor 1 (HIF1) (Ragnum et al, 2013 (link)) and androgen receptor (AR) (Massie et al, 2011 (link)), respectively. The prostate cancer-specific hypoxia gene set was generated from the expression data of four prostate cancer cell lines and included genes with more than two-fold upregulation under hypoxia in at least two cell lines (Supplementary Table S2 ).
Second, a supervised gene set enrichment analysis was performed with 21 gene sets covering the significant biological processes from the GO analysis, using the Significance Analysis of Microarrays for Gene Sets (SAM-GS) software, which is based on the moderated t-statistics in SAM (Dinu et al, 2007 ). All gene sets were collected from the Molecular Signatures Database except a prostate cancer-specific hypoxia gene set constructed in this work, two hypoxia gene sets constructed in head and neck (Toustrup et al, 2011 (link)) and cervical cancer (Halle et al, 2012 (link)) and two target gene sets of the hypoxia-inducible factor 1 (HIF1) (Ragnum et al, 2013 (link)) and androgen receptor (AR) (Massie et al, 2011 (link)), respectively. The prostate cancer-specific hypoxia gene set was generated from the expression data of four prostate cancer cell lines and included genes with more than two-fold upregulation under hypoxia in at least two cell lines (
AR protein, human
Biological Processes
Cell Lines
Cells
Cervical Cancer
Gene, Cancer
Genes
Head
Hypoxia
Hypoxia-Inducible Factor 1
Microarray Analysis
Neck
pimonidazole
Prostate
Prostate Cancer
Up-Regulation (Physiology)
Animals
Body Weight
Cecum
Clostridium
Euthanasia
Females
Infection
Injections, Intraperitoneal
Institutional Animal Care and Use Committees
isolation
Mice, House
Mice, Inbred C57BL
Mice, Inbred CBA
Microbial Community
pimonidazole
Spores
Strains
Streptomycin
Transmission, Communicable Disease
tributyrin
Tube Feeding
Vaccination
Antibodies
Antibodies, Anti-Idiotypic
Caspase 3
Hematoxylin
Heterografts
hSet2 protein, human
hypoxyprobe-1
Immunohistochemistry
Mice, House
pimonidazole
Rabbits
Stains
60 mg/kg bodyweight pimonidazole hydrochloride (Hypoxyprobe-1™ kit, Chemicon (Millipore), Livingston UK) diluted in sterile phosphate buffered saline (PBS, Invitrogen Ltd. Paisley UK) was administered by intraperitoneal injection 3 hours prior to euthanasia as previously described [26] (link). Animals were terminally anaesthetised and eyes were fixed by intracardiac perfusion with 1% paraformaldehyde in PBS pH 7.4 and post fixed in 1-4% paraformaldehyde at room temperature. Retinal cryosections were incubated for 1 hour at room temperature in PBS with 1% bovine serum albumin (BSA, Sigma Aldrich Ltd. Gillingham, UK) and 5% normal goat serum (Abd serotec, Kidlington UK) and for retinal flatmounts, 0.05% (v/v) Triton X-100 (Sigma Aldrich Ltd., Gillingham UK) was added to the blocking solution. For retinal cryosection analysis (n = 3 eyes for each time-point), 12 µm retinal sections were incubated with anti-pimonidazole antibody (FITC conjugated mouse anti pimonidazole in Hypoxyprobe-1™ kit, Chemicon, Millipore Ltd. Livingston UK) at 1∶50 dilution in blocking solution for 1 hour at room temperature. For retinal flatmount examination (n = 3 eyes for each time-point), eyecups with the cornea and lens removed were incubated with anti-pimonidazole antibody at a dilution of 1∶100 in blocking solution for 4 hours at 37°C. Counterstaining with TRITC conjugated Bandeiraea simplicifolia (BS) lectin (Sigma Aldrich, Gillingham, UK) was performed at a concentration of 0.1 mg/ml in PBS overnight at 4°C. Retinas were washed extensively in PBS and dissected from the eyecup, radial cuts were made to flatten the retina, and the retinas were mounted with fluorescent aqueous mounting medium (Dako Ltd., Ely UK) ganglion cell layer uppermost using a coverslip.
Full text: Click here
Most recents protocols related to «Pimonidazole»
For bioreductive labelling of hypoxic tissue areas, tumor bearing mice were i.v. injected with 60 mg/kg bodyweight pimonidazole (Hypoxyprobe™-1), diluted in isotonic saline. After 30 min, animals were perfused. To counterstain intracellular pimonidazole-adducts, wholemount staining of 1 mm vibratome sections or an intact BVZ-treated tumor xenograft was performed via an ATTO 594-labelled rat monoclonal α-pimonidazole antibody (clone 11.23.22.R; Hypoxyprobe Inc., Burlington, USA). Optically cleared, stained tissue samples were visualized by LSFM.
Full text: Click here
To assess intestinal hypoxia after TBI (nsham = 11, nCCI = 6–7/timepoint), mice received an intraperitoneal (i.p.) injection of 60 mg/kg pimonidazole-HCl (Hypoxyprobe-1/HP1 | Hypoxyprobe, Inc.) 1 h prior to euthanasia as per manufacturer instructions. Under hypoxic conditions, HP1 is reduced and forms protein adducts that can then be detected using antibodies against this protein adduct31 (link).
Full text: Click here
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
BALB/c mice (female, 8-week-old, purchased from CLEA Japan) were prepared. C26 cells (ca. 1 × 106 cells) were suspended in serum-free RPMI-1640 and subcutaneously inoculated to both hindlegs of the mice. After 10 days, Pimo-yne and pimonidazole hydrochloride were dissolved in the vehicle (5% v/v DMSO, 45% v/v polyethylene glycol (PEG)-400, 50% v/v DPBS(–)) and intravenously injected into the mice at 30 mg/kg each. After 2 h, the mice were anesthetized by isoflurane and perfused by sterile heparinized DPBS(–) and 4% PFA in 0.1 M PB. The tumors were extracted and fixed in 4% PFA in 0.1 M PB at 4 °C overnight. After DPBS(–) wash, the tumor tissues were immersed in sucrose solution, embedded in optimal cutting temperature (OCT) compound (#4583, Sakura Finetek Japan), and frozen on dry ice. The samples used in the following experiment were randomly chosen from the two tumors obtained from each leg of the mice. The tissue sections at a 10 μm thickness were prepared with a cryostat (CM1950, Leica) and permeabilized with 0.2% w/v Triton X-100 in DPBS(–) for 10 min. After DPBS(–) wash, the sections were treated with a CuAAC reaction solution (25 μM Cy5-PEG4-azide or CF647 azide, 1 mM CuSO4, 2 mM BTTAA, 5 mM NaAsc, 10% v/v DMSO in DPBS(–)) in the dark at r.t. for 1 h and washed with 0.2% w/v Triton X-100 in DPBS(–) three times. Then, the sections were washed with DPBS(–) three times and blocked with Protein Block Serum-Free in the dark at r.t. for 30 min. After the blocking solution was removed, the sections were incubated with anti-pimonidazole rabbit polyclonal antibody (1:100 in blocking solution, #Pab2627, Hypoxyprobe) in the dark at 4 °C overnight. (NOTE: Pimo-yne was not detected by the anti-pimonidazole antibody (data not shown)). The sections were washed with DPBS-T (0.05% v/v Tween-20 in DPBS(–)) three times and incubated with Alexa Fluor 488 (AF488)-conjugated anti-rabbit antibody (1:100 in blocking solution, #4412S, Cell Signaling Technology). The sections were washed with DPBS-T three times and mounted with DAPI fluoromount-G (#0100-20, SouthernBiotech). The sections were imaged by a fluorescence microscope (BZ-X800, Keyence) with Plan Apochromat 4X (BZ-PA04) or Plan Apochromat 10X (BZ-PA10). The acquired images were processed using Fiji [24 (link)].
Full text: Click here
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Top products related to «Pimonidazole»
Sourced in United States
Pimonidazole is a chemical compound used as a hypoxia probe. It functions by binding to cells that have low oxygen levels (hypoxic cells), allowing for the detection and quantification of hypoxia in biological samples.
Sourced in United States
The Hypoxyprobe-1 Plus Kit is a laboratory equipment used for detecting and measuring hypoxic conditions in biological samples. It contains the necessary components to perform immunohistochemical and immunofluorescent analyses to identify and quantify hypoxic cells.
Sourced in United States
Pimonidazole hydrochloride is a chemical compound used as a hypoxia marker in biological research. It is a nitroimidazole derivative that undergoes bioreductive activation in hypoxic (low oxygen) cells, forming adducts that can be detected using specific antibodies. This allows for the identification and quantification of hypoxic regions within tissue samples.
Sourced in United States, Germany, Italy, United Kingdom, Japan, China, France, Sao Tome and Principe, Canada, Macao, Belgium, Israel, Spain, Australia, Poland, Switzerland, India, Denmark, Austria, Netherlands
Hoechst 33342 is a fluorescent dye that binds to DNA. It can be used to visualize and quantify nucleic acids in various applications such as flow cytometry, fluorescence microscopy, and nucleic acid staining.
Sourced in United States
The Hypoxyprobe-1 Omni Kit is a laboratory tool used to detect and measure hypoxia, or low oxygen levels, in biological samples. The kit contains reagents and accessories necessary for the immunohistochemical detection of hypoxic cells using the Hypoxyprobe-1 (pimonidazole) marker.
Sourced in United States, Germany, United Kingdom, Japan, China, Canada, Italy, Australia, France, Switzerland, Spain, Belgium, Denmark, Panama, Poland, Singapore, Austria, Morocco, Netherlands, Sweden, Argentina, India, Finland, Pakistan, Cameroon, New Zealand
DAPI is a fluorescent dye used in microscopy and flow cytometry to stain cell nuclei. It binds strongly to the minor groove of double-stranded DNA, emitting blue fluorescence when excited by ultraviolet light.
Sourced in United States
Pimonidazole-HCl is a chemical compound that can be used as a hypoxia marker. It is a water-soluble, nitroimidazole-based compound that undergoes bioreductive activation in hypoxic cells, forming stable adducts with thiol-containing proteins. This property allows for the detection and quantification of hypoxic areas within tissues.
Sourced in United States
Anti-pimonidazole antibodies are laboratory reagents used to detect the presence of pimonidazole, a chemical compound used as a hypoxia marker. These antibodies bind specifically to pimonidazole, allowing for the identification and quantification of hypoxic regions in biological samples.
Sourced in United States, Germany, United Kingdom, Japan, China, France, Canada, Spain, Belgium, Italy, Australia, Austria, Denmark, Netherlands, Switzerland, Ireland, New Zealand, Portugal, Brazil, Argentina, Singapore, Poland, Ukraine, Macao, Thailand, Finland, Lithuania, Sweden
Hoechst 33342 is a fluorescent dye that binds to DNA. It is commonly used in various applications, such as cell staining and flow cytometry, to identify and analyze cell populations.